Literature DB >> 2582721

Reduced selenium status of patients with asthma.

J Stone1, L J Hinks, R Beasley, S T Holgate, B A Clayton.   

Abstract

1. Selenium is an essential component of glutathione peroxidase (GSH-Px, EC 1.11.1.9), an enzyme which helps protects cells against damage caused by free radicals and hydroperoxides. 2. We report the plasma, whole blood and platelet concentrations of selenium, and whole blood and platelet activities of GSH-Px, in 49 patients with asthma, 23 of whom had coexisting eczema, and 76 healthy control subjects. 3. The asthmatic patients had significantly lower concentrations of selenium measured in plasma (P less than 0.001) and whole blood (P less than 0.001), but not in platelets. When the data were summarized as odds ratios there was a highly significant 3.54- and 5.08-fold increased probability of asthma observed for the lower range of plasma and whole blood selenium concentrations, respectively. 4. No overall decrease in platelet or whole blood GSH-Px activity was found when the asthmatic and control groups were compared. 5. Although patients with symptomatic asthma have a reduced selenium status, this does not appear to influence the antioxidant capacity of their circulating blood cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2582721     DOI: 10.1042/cs0770495

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  21 in total

Review 1.  Why don't we give chest patients dietary advice?

Authors:  G Devereux; A Seaton
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

2.  Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma.

Authors:  L G Wood; D A Fitzgerald; P G Gibson; D M Cooper; M L Garg
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

3.  Asthma.

Authors: 
Journal:  J Epidemiol Community Health       Date:  1990-09       Impact factor: 3.710

Review 4.  Glutathione redox control of asthma: from molecular mechanisms to therapeutic opportunities.

Authors:  Anne M Fitzpatrick; Dean P Jones; Lou Ann S Brown
Journal:  Antioxid Redox Signal       Date:  2012-03-09       Impact factor: 8.401

Review 5.  The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities.

Authors:  Zhi Huang; Aaron H Rose; Peter R Hoffmann
Journal:  Antioxid Redox Signal       Date:  2012-01-09       Impact factor: 8.401

6.  Dietary supplements and asthma: another one bites the dust.

Authors:  Johanna Feary; John Britton
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

Review 7.  Complementary and alternative medicine and asthma.

Authors:  R M Hackman; J S Stern; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

8.  Reduced selenium in asthmatic subjects in New Zealand.

Authors:  A Flatt; N Pearce; C D Thomson; M R Sears; M F Robinson; R Beasley
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

9.  In vitro release of arachidonic acid metabolites, glutathione peroxidase, and oxygen-free radicals from platelets of asthmatic patients with and without aspirin intolerance.

Authors:  V Plaza; J Prat; J Rosellò; E Ballester; I Ramis; J Mullol; E Gelpí; J L Vives-Corrons; C Picado
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

10.  Selenium status is decreased in patients with intrinsic asthma.

Authors:  J Kadrabová; A Mad'aric; Z Kovaciková; F Podivínsky; E Ginter; F Gazdík
Journal:  Biol Trace Elem Res       Date:  1996-06       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.